Search This Blog

Saturday, January 21, 2023

COVID-19 convalescent plasma for the treatment of immunocompromised patients

 About The Study: The findings this systematic review and meta-analysis suggest that transfusion of COVID-19 convalescent plasma is associated with mortality benefit for patients who are immunocompromised and have COVID-19. 

Authors: Jonathon W. Senefeld, Ph.D., of the Mayo Clinic in Rochester, Minnesota, is the corresponding author. 

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamanetworkopen.2022.50647)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.50647?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=01122

https://www.eurekalert.org/news-releases/976243

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.